HUT67599A - Process for producing dry- processed particles, the produced dry-processed particles, and pharmaceutical compositions containing them - Google Patents

Process for producing dry- processed particles, the produced dry-processed particles, and pharmaceutical compositions containing them

Info

Publication number
HUT67599A
HUT67599A HU9401412A HU9401412A HUT67599A HU T67599 A HUT67599 A HU T67599A HU 9401412 A HU9401412 A HU 9401412A HU 9401412 A HU9401412 A HU 9401412A HU T67599 A HUT67599 A HU T67599A
Authority
HU
Hungary
Prior art keywords
processed particles
dry
pharmaceutical compositions
compositions containing
produced
Prior art date
Application number
HU9401412A
Other languages
Hungarian (hu)
Other versions
HU9401412D0 (en
HU220617B1 (en
Inventor
Jean-Marc Ruiz
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of HU9401412D0 publication Critical patent/HU9401412D0/en
Publication of HUT67599A publication Critical patent/HUT67599A/en
Publication of HU220617B1 publication Critical patent/HU220617B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
HU9401412A 1993-05-15 1994-05-06 Dissolution-free process for producing particles containing active ingredient, the produced particles, and pharmaceutical compositions containing them HU220617B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same

Publications (3)

Publication Number Publication Date
HU9401412D0 HU9401412D0 (en) 1994-08-29
HUT67599A true HUT67599A (en) 1995-04-28
HU220617B1 HU220617B1 (en) 2002-03-28

Family

ID=10735537

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401412A HU220617B1 (en) 1993-05-15 1994-05-06 Dissolution-free process for producing particles containing active ingredient, the produced particles, and pharmaceutical compositions containing them

Country Status (35)

Country Link
JP (1) JP3139913B2 (en)
KR (1) KR100341261B1 (en)
CN (1) CN1050534C (en)
AT (1) AT406017B (en)
AU (1) AU685094B2 (en)
BE (1) BE1008323A3 (en)
BR (1) BR9401968A (en)
CA (1) CA2123481C (en)
CH (1) CH688572A5 (en)
DE (1) DE4416812C2 (en)
DK (1) DK171454B1 (en)
DZ (1) DZ1779A1 (en)
ES (1) ES2097083B1 (en)
FI (1) FI112915B (en)
FR (1) FR2705232B1 (en)
GB (2) GB9310030D0 (en)
GR (1) GR1002034B (en)
HK (1) HK1002831A1 (en)
HU (1) HU220617B1 (en)
IE (1) IE940392A1 (en)
IN (1) IN182330B (en)
IT (1) IT1269508B (en)
LU (1) LU88482A1 (en)
MA (1) MA23194A1 (en)
NL (1) NL9400795A (en)
NO (1) NO307403B1 (en)
NZ (1) NZ260520A (en)
OA (1) OA09939A (en)
PL (1) PL175780B1 (en)
PT (1) PT101518B (en)
RU (1) RU2125869C1 (en)
SE (1) SE519004C2 (en)
SG (1) SG46631A1 (en)
TN (1) TNSN94046A1 (en)
ZA (1) ZA943316B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47043A1 (en) * 1993-01-06 1998-03-20 Kinerton Ltd Ionic molecular conjugates of biodegradeble polyesters and bioactive polypeptides
EP1203591B1 (en) * 1993-01-06 2007-12-19 Ipsen Manufacturing Ireland Limited biodegradable polyesters for forming ionic molecular conjugates with bioactive polypeptides
DE19604744A1 (en) 1996-02-09 1997-08-14 Henkel Kgaa Technical di- / triglyceride mixtures
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DE19617137C1 (en) * 1996-04-29 1997-02-27 Henkel Kgaa Use of branched alcohol ester(s) of olefin-di:carboxylic acid copolymers
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
CA2685349C (en) 1999-11-15 2013-09-17 Bio Syntech Canada Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
GB2374072B (en) * 2000-06-16 2004-09-22 Nippon Catalytic Chem Ind Crosslinked polymer method for manufacturing it and use thereof
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH672887A5 (en) * 1987-10-14 1990-01-15 Debiopharm Sa
WO1989003678A1 (en) * 1987-10-30 1989-05-05 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
DE3916020C2 (en) * 1989-05-17 1994-06-01 Burkhard Dr Wichert Retarding microparticles made from biodegradable polyesters; Process for their preparation without the use of toxic solvents and pharmaceutical preparations containing these microparticles
JP3191948B2 (en) * 1990-04-12 2001-07-23 塩野義製薬株式会社 Coated preparation and method for producing the same
JP3116311B2 (en) * 1990-06-13 2000-12-11 エーザイ株式会社 Manufacturing method of microsphere
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
SE9003296L (en) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab PROCEDURE SHOULD FORMULATE MEDICINAL PRODUCTS
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
SE9101603L (en) * 1991-05-27 1992-09-21 Bengt Hjalmar Aagerup Med Firm METHOD FOR MAKING REPRODUCABLE PARTICLES OF DEFINED SIZE
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
DE69311538D1 (en) * 1992-03-12 1997-07-17 Alkermes Inc ACTH CONTAINED MICROBALLS WITH CONTROLLED DISCHARGE
SE9200858L (en) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Method for producing delayed release pellets
DK0644771T4 (en) * 1992-06-11 2006-12-27 Alkermes Inc Drug system for the delivery of erythropoietin
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
JP2651320B2 (en) * 1992-07-16 1997-09-10 田辺製薬株式会社 Method for producing sustained-release microsphere preparation
FR2693905B1 (en) * 1992-07-27 1994-09-02 Rhone Merieux Process for the preparation of microspheres for the sustained release of the hormone LHRH and its analogs, microspheres and formulations obtained.
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix

Also Published As

Publication number Publication date
LU88482A1 (en) 1994-12-01
ATA98794A (en) 1999-06-15
AU685094B2 (en) 1998-01-15
CA2123481C (en) 2005-01-11
AT406017B (en) 2000-01-25
PT101518A (en) 1995-03-01
ES2097083B1 (en) 1997-12-01
HK1002831A1 (en) 1998-09-18
KR100341261B1 (en) 2002-09-27
PL175780B1 (en) 1999-02-26
GR1002034B (en) 1995-10-31
IT1269508B (en) 1997-04-01
TNSN94046A1 (en) 1995-04-25
FR2705232B1 (en) 1995-08-25
GB9409565D0 (en) 1994-07-06
NL9400795A (en) 1994-12-01
CN1104557A (en) 1995-07-05
PT101518B (en) 2000-12-29
MA23194A1 (en) 1994-12-31
NZ260520A (en) 1994-12-22
DE4416812C2 (en) 2003-02-06
OA09939A (en) 1994-11-15
SE9401557D0 (en) 1994-05-05
BE1008323A3 (en) 1996-04-02
GB9310030D0 (en) 1993-06-30
IE940392A1 (en) 1994-11-16
NO941810D0 (en) 1994-05-13
ES2097083A1 (en) 1997-03-16
ITMI940931A1 (en) 1995-11-11
JPH072652A (en) 1995-01-06
FI942222A (en) 1994-11-16
GB2277915B (en) 1997-10-29
FR2705232A1 (en) 1994-11-25
SE519004C2 (en) 2002-12-17
SG46631A1 (en) 1998-02-20
HU9401412D0 (en) 1994-08-29
CH688572A5 (en) 1997-11-28
FI942222A0 (en) 1994-05-13
ZA943316B (en) 1995-01-16
JP3139913B2 (en) 2001-03-05
DK54994A (en) 1994-11-16
GB2277915A (en) 1994-11-16
AU6308494A (en) 1994-11-17
NO307403B1 (en) 2000-04-03
SE9401557L (en) 1994-11-16
DK171454B1 (en) 1996-11-04
BR9401968A (en) 1994-12-13
CA2123481A1 (en) 1994-11-16
DE4416812A1 (en) 1994-11-17
ITMI940931A0 (en) 1994-05-11
RU2125869C1 (en) 1999-02-10
DZ1779A1 (en) 2002-02-17
FI112915B (en) 2004-02-13
NO941810L (en) 1994-11-16
IN182330B (en) 1999-03-20
CN1050534C (en) 2000-03-22
HU220617B1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
EP0590263A3 (en) Gas barrier resin composition and process for producing the same
HUP9603495A2 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
HUT70616A (en) Carboxamides, pharmaceutical compositions containing them and process for producing them
HUP9900055A3 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them
HUT64734A (en) Anthraquinone-derivativdes, process for preparing them and pharmaceutical compositions containing them
HUT60784A (en) Process for producing n,o-sulfated heparosanes and pharmaceutical compositions comprising such compounds
HUP9603433A3 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
HUP9601358A2 (en) Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them
PH31073A (en) Pharmaceutical composition and process for the preparation thereof.
HUT67599A (en) Process for producing dry- processed particles, the produced dry-processed particles, and pharmaceutical compositions containing them
HUT67142A (en) Spirostanil glycosidal cristalline monohydrate, pharmaceutical compositions containing the same and process for their production
SG83634A1 (en) Resin compositions, production process thereof, and products using the resin compositions
HU9400934D0 (en) Thiadiazinone derivatives, pharmaceutical compositions containing them and process for producing them
HUT74615A (en) 2,3-cyclic-condensed-1,4-dihydro-pyridine derivatives, process for producing them and pharmaceutical compositions containing the same
HUT68320A (en) Fluorinated 4-amino-androstadiene-derivatives, pharmaceutical composition containing the same and process for producing them
HUP9601331A3 (en) Piperazine- and homopiperazine-derivatives, process for producing them and pharmaceutical compositions containing them
HU9503932D0 (en) Substituted benzol-sulfonyl-ureas and-thioureas, pharmaceutical compositions containing them and process for producing them
ZA957322B (en) Tetrahydropyran compounds process for the preparation thereof and pharmaceutical compositions containing them
HU9402919D0 (en) Heteroaryl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0004459A3 (en) 2,4,4-trisubstituted-1,3-dioxolane antifungals, process for producing them and pharmaceutical compositions containing the same
HUT68249A (en) 2,6-methano-2h-quinolizin derivative as 5-ht3-receptor and pharmaceutical composition containing it and process for producing thereof
HU9400909D0 (en) 1,2,5,6-terrahydro-pyridine derivative pharmaceutical compositions containing them and process for producing them
HU9503931D0 (en) Substituted benzol-sulfonyl-ureas and -thioureas, pharmaceutical compositions containing them and process for producing them
HK1001395A1 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees